Biocon Biologics initiates clinical study for Itolizumab in Lupus Nephritis
Equalise is a phase-Ib open-label, proof-of-concept clinical study currently studying Lupus Nephritis patients in the Part B…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.